Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACT.

Unseld M, Mader R, Baumann L, Veraar C, Wrba F, Waneck F, Kieler M, Bianconi D, Berger W, Sibilia M, Müllauer L, Zielinski C, Prager GW.

Chin J Cancer Res. 2018 Oct;30(5):508-515. doi: 10.21147/j.issn.1000-9604.2018.05.04.

2.

A meta-analysis of melanoma risk in industrial workers.

Vujic I, Gandini S, Stanganelli I, Fierro MT, Rappersberger K, Sibilia M, Tosti G, Ferrucci PF, Caini S, De Felici MB, Pagliarello C, Quaglino P, Sanlorenzo M; on behalf of IMI, the Italian Melanoma Intergroup.

Melanoma Res. 2018 Oct 26. doi: 10.1097/CMR.0000000000000531. [Epub ahead of print]

PMID:
30371537
3.

EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.

Linder M, Glitzner E, Srivatsa S, Bakiri L, Matsuoka K, Shahrouzi P, Dumanic M, Novoszel P, Mohr T, Langer O, Wanek T, Mitterhauser M, Wagner EF, Sibilia M.

EMBO Mol Med. 2018 Nov;10(11). pii: e9408. doi: 10.15252/emmm.201809408.

4.

RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure.

Jain M, Mann TD, Stulić M, Rao SP, Kirsch A, Pullirsch D, Strobl X, Rath C, Reissig L, Moreth K, Klein-Rodewald T, Bekeredjian R, Gailus-Durner V, Fuchs H, Hrabě de Angelis M, Pablik E, Cimatti L, Martin D, Zinnanti J, Graier WF, Sibilia M, Frank S, Levanon EY, Jantsch MF.

EMBO J. 2018 Oct 1;37(19). pii: e94813. doi: 10.15252/embj.201694813. Epub 2018 Aug 7.

5.

Impaired neural stem cell expansion and hypersensitivity to epileptic seizures in mice lacking the EGFR in the brain.

Robson JP, Wagner B, Glitzner E, Heppner FL, Steinkellner T, Khan D, Petritsch C, Pollak DD, Sitte HH, Sibilia M.

FEBS J. 2018 Sep;285(17):3175-3196. doi: 10.1111/febs.14603. Epub 2018 Aug 4.

6.

Afatinib restrains K-RAS-driven lung tumorigenesis.

Moll HP, Pranz K, Musteanu M, Grabner B, Hruschka N, Mohrherr J, Aigner P, Stiedl P, Brcic L, Laszlo V, Schramek D, Moriggl R, Eferl R, Moldvay J, Dezso K, Lopez-Casas PP, Stoiber D, Hidalgo M, Penninger J, Sibilia M, Győrffy B, Barbacid M, Dome B, Popper H, Casanova E.

Sci Transl Med. 2018 Jun 20;10(446). pii: eaao2301. doi: 10.1126/scitranslmed.aao2301.

PMID:
29925635
7.

Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.

Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, Shalapour S, Yang L, Valasek MA, Lee S, Minnich K, Seki E, Tuckermann J, Sibilia M, Zucman-Rossi J, Karin M.

Cancer Cell. 2018 Jun 11;33(6):1061-1077.e6. doi: 10.1016/j.ccell.2018.05.003.

PMID:
29894692
8.

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, Dinhof C, Schueffl HH, Sramko M, Hoebart J, Alioglu F, Grusch M, Ogris M, Lubitz W, Keppler BK, Pashkunova-Martic I, Kowol CR, Sibilia M, Berger W, Heffeter P.

Oncoimmunology. 2018 Feb 16;7(5):e1424676. doi: 10.1080/2162402X.2018.1424676. eCollection 2018.

PMID:
29721389
9.

BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody.

Sanlorenzo M, Vujic I, Floris A, Novelli M, Gammaitoni L, Giraudo L, Macagno M, Leuci V, Rotolo R, Donini C, Basiricò M, Quaglino P, Fierro MT, Giordano S, Sibilia M, Carnevale-Schianca F, Aglietta M, Sangiolo D.

Clin Cancer Res. 2018 Jul 15;24(14):3377-3385. doi: 10.1158/1078-0432.CCR-17-1914. Epub 2018 Apr 12.

PMID:
29650750
10.

Osteopontin-deficient progenitor cells display enhanced differentiation to adipocytes.

Moreno-Viedma V, Tardelli M, Zeyda M, Sibilia M, Burks JD, Stulnig TM.

Obes Res Clin Pract. 2018 May - Jun;12(3):277-285. doi: 10.1016/j.orcp.2018.02.006. Epub 2018 Mar 6.

PMID:
29519755
11.

ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.

Schmidt S, Schumacher N, Schwarz J, Tangermann S, Kenner L, Schlederer M, Sibilia M, Linder M, Altendorf-Hofmann A, Knösel T, Gruber ES, Oberhuber G, Bolik J, Rehman A, Sinha A, Lokau J, Arnold P, Cabron AS, Zunke F, Becker-Pauly C, Preaudet A, Nguyen P, Huynh J, Afshar-Sterle S, Chand AL, Westermann J, Dempsey PJ, Garbers C, Schmidt-Arras D, Rosenstiel P, Putoczki T, Ernst M, Rose-John S.

J Exp Med. 2018 Apr 2;215(4):1205-1225. doi: 10.1084/jem.20171696. Epub 2018 Feb 22.

12.

EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

Linder M, Hecking M, Glitzner E, Zwerina K, Holcmann M, Bakiri L, Ruocco MG, Tuckermann J, Schett G, Wagner EF, Sibilia M.

Cell Death Differ. 2018 Jun;25(6):1094-1106. doi: 10.1038/s41418-017-0054-7. Epub 2018 Feb 14.

13.

Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.

Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Teoh EJ, Bottomley D, Scarsbrook A, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Chau A, Ward P, Miller MP, Stevens DJ, Wilson L, Gleeson FV, Scheidhauer K, Seidl C, Autenrieth M, Bruchertseifer F, Apostolidis C, Kurtz F, Horn T, Pfob C, Schwaiger M, Gschwend J, D'Alessandria C, Morgenstern A, Uprimny C, Kroiss A, Decristoforo C, von Guggenberg E, Nilica B, Horninger W, Virgolini I, Rasul S, Poetsch N, Woehrer A, Preusser M, Mitterhauser M, Wadsak W, Widhalm G, Mischkulnig M, Hacker M, Traub-Weidinger T, Wright CL, Binzel K, Wuthrick EJ, Miller ED, Maniawski P, Zhang J, Knopp MV, Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L, Mairinger S, Filip T, Sauberer M, Flunkert S, Wanek T, Stanek J, Okamura N, Langer O, Kuntner C, Fornito MC, Balzano R, Di Martino V, Cacciaguerra S, Russo G, Seifert D, Kleinova M, Cepa A, Ralis J, Hanc P, Lebeda O, Mosa M, Vandenberghe S, Mikhaylova E, Borys D, Viswanath V, Stockhoff M, Efthimiou N, Caribe P, Van Holen R, Karp JS, Binzel K, Zhang J, Wright CL, Maniawski P, Knopp MV, Haller PM, Farhan C, Piackova E, Jäger B, Knoll P, Kiss A, Podesser BK, Wojta J, Huber K, Mirzaei S, Traxl A, Komposch K, Glitzner E, Wanek T, Mairinger S, Sibilia M, Langer O, Fornito MC, Russello M, Russo G, Balzano R, Sorko S, Gallowitsch HJ, Kohlfuerst S, Matschnig S, Rieser M, Sorschag M, Lind P, Ležaič L, Rep S, Žibert J, Frelih N, Šuštar S, Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Baum RP, Langbein T, Singh A, Shahinfar M, Schuchardt C, Volk GF, Kulkarni HR, Fornito MC, Cacciaguerra S, Balzano R, Di Martino GV, Russo G, Thomson WH, Kudlacek M, Karik M, Farhan C, Rieger H, Pokieser W, Glaser K, Mirzaei S, Petz V, Tugendsam C, Buchinger W, Schmoll-Hauer B, Schenk IP, Rudolph K, Krebs M, Zettinig G, Zoufal V, Wanek T, Krohn M, Mairinger S, Stanek J, Sauberer M, Filip T, Pahnke J, Langer O, Weitzer F, Pernthaler B, Salamon S, Aigner R, Koranda P, Henzlová L, Kamínek M, Váchalová M, Bachleda P, Summer D, Garousi J, Oroujeni M, Mitran B, Andersson KG, Vorobyeva A, Löfblom JN, Orlova A, Tolmachev V, Decristoforo C, Kaeopookum P, Summer D, Orasch T, Lechner B, Petrik M, Novy Z, Rangger C, Haas H, Decristoforo C.

EJNMMI Res. 2018 Jan 23;8(Suppl 1):5. doi: 10.1186/s13550-017-0354-4. No abstract available.

14.

Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion.

Minutti CM, Drube S, Blair N, Schwartz C, McCrae JC, McKenzie AN, Kamradt T, Mokry M, Coffer PJ, Sibilia M, Sijts AJ, Fallon PG, Maizels RM, Zaiss DM.

Immunity. 2017 Oct 17;47(4):710-722.e6. doi: 10.1016/j.immuni.2017.09.013.

15.

Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.

Kral M, Klimek C, Kutay B, Timelthaler G, Lendl T, Neuditschko B, Gerner C, Sibilia M, Csiszar A.

FEBS J. 2017 Oct;284(20):3484-3505. doi: 10.1111/febs.14207. Epub 2017 Sep 14.

16.

Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography.

Traxl A, Komposch K, Glitzner E, Wanek T, Mairinger S, Langer O, Sibilia M.

Drug Metab Dispos. 2017 Oct;45(10):1093-1100. doi: 10.1124/dmd.117.077081. Epub 2017 Aug 8.

17.

EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.

Katschnig AM, Kauer MO, Schwentner R, Tomazou EM, Mutz CN, Linder M, Sibilia M, Alonso J, Aryee DNT, Kovar H.

Oncogene. 2017 Oct 26;36(43):5995-6005. doi: 10.1038/onc.2017.202. Epub 2017 Jul 3.

18.

EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.

Srivatsa S, Paul MC, Cardone C, Holcmann M, Amberg N, Pathria P, Diamanti MA, Linder M, Timelthaler G, Dienes HP, Kenner L, Wrba F, Prager GW, Rose-John S, Eferl R, Liguori G, Botti G, Martinelli E, Greten FR, Ciardiello F, Sibilia M.

Gastroenterology. 2017 Jul;153(1):178-190.e10. doi: 10.1053/j.gastro.2017.03.053. Epub 2017 Apr 9.

19.

Correction: Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart.

Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, Wagner EF.

Development. 2016 Dec 15;143(24):4755. No abstract available.

20.

Plasma diagnostics in spherical tokamaks with silicon charged-particle detectors.

Netepenko A, Boeglin WU, Darrow DS, Ellis R, Sibilia MJ.

Rev Sci Instrum. 2016 Nov;87(11):11D805.

PMID:
27910355
21.

Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle Progression.

Amberg N, Holcmann M, Stulnig G, Sibilia M.

J Invest Dermatol. 2016 Nov;136(11):2140-2149. doi: 10.1016/j.jid.2016.06.613. Epub 2016 Jul 1.

22.

Effects of Depilation Methods on Imiquimod-Induced Skin Inflammation in Mice.

Amberg N, Holcmann M, Stulnig G, Glitzner E, Sibilia M.

J Invest Dermatol. 2017 Feb;137(2):528-531. doi: 10.1016/j.jid.2016.09.018. Epub 2016 Sep 30. No abstract available.

23.

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.

Svinka J, Pflügler S, Mair M, Marschall HU, Hengstler JG, Stiedl P, Poli V, Casanova E, Timelthaler G, Sibilia M, Eferl R.

J Mol Med (Berl). 2017 Jan;95(1):109-117. doi: 10.1007/s00109-016-1462-8. Epub 2016 Aug 27.

24.

[Guidelines for vaccination of immunocompromised individuals].

Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, Kitchen M, Köller M, Kollaritsch H, Kundi M, Lassmann H, Mutz I, Pickl WF, Riedl E, Sibilia M, Thalhammer F, Tucek B, Zenz W, Zwiauer K.

Wien Klin Wochenschr. 2016 Aug;128 Suppl 4:337-76. doi: 10.1007/s00508-016-1033-6. Epub 2016 Jul 25. German.

PMID:
27457874
25.

Mechanisms underlying skin disorders induced by EGFR inhibitors.

Holcmann M, Sibilia M.

Mol Cell Oncol. 2015 Jun 1;2(4):e1004969. doi: 10.1080/23723556.2015.1004969. eCollection 2015 Oct-Dec. Review.

26.

Evidence That Cingulin Regulates Endothelial Barrier Function In Vitro and In Vivo.

Schossleitner K, Rauscher S, Gröger M, Friedl HP, Finsterwalder R, Habertheuer A, Sibilia M, Brostjan C, Födinger D, Citi S, Petzelbauer P.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):647-54. doi: 10.1161/ATVBAHA.115.307032. Epub 2016 Jan 28.

PMID:
26821949
27.

Requirement of Stat3 Signaling in the Postnatal Development of Thymic Medullary Epithelial Cells.

Satoh R, Kakugawa K, Yasuda T, Yoshida H, Sibilia M, Katsura Y, Levi B, Abramson J, Koseki Y, Koseki H, van Ewijk W, Hollander GA, Kawamoto H.

PLoS Genet. 2016 Jan 20;12(1):e1005776. doi: 10.1371/journal.pgen.1005776. eCollection 2016 Jan.

28.

EGFR Signaling in Liver Diseases.

Komposch K, Sibilia M.

Int J Mol Sci. 2015 Dec 29;17(1). pii: E30. doi: 10.3390/ijms17010030. Review.

29.

SNEV(Prp19/PSO4) deficiency increases PUVA-induced senescence in mouse skin.

Monteforte R, Beilhack GF, Grausenburger R, Mayerhofer B, Bittner R, Grillari-Voglauer R, Sibilia M, Dellago H, Tschachler E, Gruber F, Grillari J.

Exp Dermatol. 2016 Mar;25(3):212-7. doi: 10.1111/exd.12910.

30.

Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.

Schreier B, Hünerberg M, Rabe S, Mildenberger S, Bethmann D, Heise C, Sibilia M, Offermanns S, Gekle M.

Clin Sci (Lond). 2016 Jan;130(1):19-33. doi: 10.1042/CS20150503. Epub 2015 Oct 5.

PMID:
26438881
31.

Temporo-mandibular joint chondrosarcoma: Case report and review of the literature.

Giorgione C, Passali FM, Varakliotis T, Sibilia M, Ottaviani F.

Acta Otorhinolaryngol Ital. 2015 Jun;35(3):208-11. Review.

32.

CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.

Brunner PM, Glitzner E, Reininger B, Klein I, Stary G, Mildner M, Uhrin P, Sibilia M, Stingl G.

Exp Dermatol. 2015 Jul;24(7):522-8. doi: 10.1111/exd.12709. Epub 2015 May 4.

PMID:
25828150
33.

Mouse models of nonmelanoma skin cancer.

Amberg N, Holcmann M, Glitzner E, Novoszel P, Stulnig G, Sibilia M.

Methods Mol Biol. 2015;1267:217-50. doi: 10.1007/978-1-4939-2297-0_10.

PMID:
25636471
34.

Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor.

Schreier B, Rabe S, Winter S, Ruhs S, Mildenberger S, Schneider B, Sibilia M, Gotthardt M, Kempe S, Mäder K, Grossmann C, Gekle M.

Sci Rep. 2014 Dec 11;4:7430. doi: 10.1038/srep07430.

35.

Specific roles for dendritic cell subsets during initiation and progression of psoriasis.

Glitzner E, Korosec A, Brunner PM, Drobits B, Amberg N, Schonthaler HB, Kopp T, Wagner EF, Stingl G, Holcmann M, Sibilia M.

EMBO Mol Med. 2014 Oct;6(10):1312-27. doi: 10.15252/emmm.201404114.

36.

EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.

Lanaya H, Natarajan A, Komposch K, Li L, Amberg N, Chen L, Wculek SK, Hammer M, Zenz R, Peck-Radosavljevic M, Sieghart W, Trauner M, Wang H, Sibilia M.

Nat Cell Biol. 2014 Oct;16(10):972-7. doi: 10.1038/ncb3031. Epub 2014 Aug 31.

37.

Autophagy regulation in pancreatic acinar cells is independent of epidermal growth factor receptor signaling.

Ozaki N, Fukuchi Y, Tomiyoshi SR, Uehara H, Ida S, Wang J, Araki K, Sibilia M, Baba H, Yamamura K, Ohmuraya M.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):224-30. doi: 10.1016/j.bbrc.2014.02.111. Epub 2014 Mar 4.

PMID:
24607897
38.

Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension.

Alias S, Redwan B, Panzenboeck A, Winter MP, Schubert U, Voswinckel R, Frey MK, Jakowitsch J, Alimohammadi A, Hobohm L, Mangold A, Bergmeister H, Sibilia M, Wagner EF, Mayer E, Klepetko W, Hoelzenbein TJ, Preissner KT, Lang IM.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):810-819. doi: 10.1161/ATVBAHA.113.302991. Epub 2014 Feb 13.

39.

TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Horak P, Tomasich E, Vaňhara P, Kratochvílová K, Anees M, Marhold M, Lemberger CE, Gerschpacher M, Horvat R, Sibilia M, Pils D, Krainer M.

Sci Rep. 2014 Jan 17;4:3739. doi: 10.1038/srep03739.

40.

EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship.

Sayar BS, Rüegg S, Schmidt E, Sibilia M, Siffert M, Suter MM, Galichet A, Müller EJ.

Exp Dermatol. 2014 Jan;23(1):33-8. doi: 10.1111/exd.12290.

PMID:
24279293
41.

Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis.

Winter M, Moser MA, Meunier D, Fischer C, Machat G, Mattes K, Lichtenberger BM, Brunmeir R, Weissmann S, Murko C, Humer C, Meischel T, Brosch G, Matthias P, Sibilia M, Seiser C.

EMBO J. 2013 Dec 11;32(24):3176-91. doi: 10.1038/emboj.2013.243. Epub 2013 Nov 15.

42.

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

Lichtenberger BM, Gerber PA, Holcmann M, Buhren BA, Amberg N, Smolle V, Schrumpf H, Boelke E, Ansari P, Mackenzie C, Wollenberg A, Kislat A, Fischer JW, Röck K, Harder J, Schröder JM, Homey B, Sibilia M.

Sci Transl Med. 2013 Aug 21;5(199):199ra111. doi: 10.1126/scitranslmed.3005886.

43.

Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.

Zaiss DM, van Loosdregt J, Gorlani A, Bekker CP, Gröne A, Sibilia M, van Bergen en Henegouwen PM, Roovers RC, Coffer PJ, Sijts AJ.

Immunity. 2013 Feb 21;38(2):275-84. doi: 10.1016/j.immuni.2012.09.023. Epub 2013 Jan 17.

44.

How imiquimod licenses plasmacytoid dendritic cells to kill tumors.

Holcmann M, Drobits B, Sibilia M.

Oncoimmunology. 2012 Dec 1;1(9):1661-1663.

45.

Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy.

Schreier B, Rabe S, Schneider B, Bretschneider M, Rupp S, Ruhs S, Neumann J, Rueckschloss U, Sibilia M, Gotthardt M, Grossmann C, Gekle M.

Hypertension. 2013 Feb;61(2):333-40. doi: 10.1161/HYPERTENSIONAHA.112.196543. Epub 2012 Dec 17.

PMID:
23248150
46.

EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.

Navas C, Hernández-Porras I, Schuhmacher AJ, Sibilia M, Guerra C, Barbacid M.

Cancer Cell. 2012 Sep 11;22(3):318-30. doi: 10.1016/j.ccr.2012.08.001.

47.

EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, Liou GY, Storz P, Murray NR, Threadgill DW, Sibilia M, Washington MK, Wilson CL, Schmid RM, Raines EW, Crawford HC, Siveke JT.

Cancer Cell. 2012 Sep 11;22(3):304-17. doi: 10.1016/j.ccr.2012.07.024.

48.

Sports nutrition knowledge among collegiate athletes, coaches, athletic trainers, and strength and conditioning specialists.

Torres-McGehee TM, Pritchett KL, Zippel D, Minton DM, Cellamare A, Sibilia M.

J Athl Train. 2012 Mar-Apr;47(2):205-11.

49.

Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.

Eberl M, Klingler S, Mangelberger D, Loipetzberger A, Damhofer H, Zoidl K, Schnidar H, Hache H, Bauer HC, Solca F, Hauser-Kronberger C, Ermilov AN, Verhaegen ME, Bichakjian CK, Dlugosz AA, Nietfeld W, Sibilia M, Lehrach H, Wierling C, Aberger F.

EMBO Mol Med. 2012 Mar;4(3):218-33. doi: 10.1002/emmm.201100201. Epub 2012 Feb 1.

50.

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.

Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M.

J Clin Invest. 2012 Feb;122(2):575-85. doi: 10.1172/JCI61034. Epub 2012 Jan 17.

Supplemental Content

Loading ...
Support Center